The Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) Polymorphism Is Associated with Risk of Scleroderma-Related Interstitial Lung Disease: A Multicenter Study From the EULAR Scleroderma Trial and Research Group.

Otylia M. Kowal-Bielecka; Sylwia Chwiesko-Minarowska; Pawel Bernatowicz; Yannick Allanore; Timothy R. D. Radstake; Jasper Broen; Marco Matucci-Cerinic; Roger Hesselstrand; Dorota Krasowska; Gabriela Riemekasten; Madelon C. Vonk; Oksana Kowalczuk; Marek Bielecki; Robert Milewski; Lech Chyczewski; Jacek Niklinski; Krzysztof Kowal

The Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) Polymorphism Is Associated with Risk of Scleroderma-Related Interstitial Lung Disease: A Multicenter Study From the EULAR Scleroderma Trial and Research Group.

Otylia M. Kowal-Bielecka, Sylwia Chwiesko-Minarowska, Pawel Bernatowicz, Yannick Allanore, Timothy R. D. Radstake, Jasper Broen, Marco Matucci-Cerinic, Roger Hesselstrand, Dorota Krasowska, Gabriela Riemekasten, Madelon C. Vonk, Oksana Kowalczuk, Marek Bielecki, Robert Milewski, Lech Chyczewski, Jacek Niklinski, Krzysztof Kowal

Infection & Immunity

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	English
Pages (from-to)	S971-S971
Number of pages	1
Journal	Arthritis and Rheumatism
Volume	64
Issue number	10
Publication status	Published - Oct 2012
Event	Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP) - Washington, Netherlands Duration: 9 Nov 2012 → 14 Nov 2012

Cite this

Kowal-Bielecka, O. M., Chwiesko-Minarowska, S., Bernatowicz, P., Allanore, Y., Radstake, T. R. D., Broen, J., Matucci-Cerinic, M., Hesselstrand, R., Krasowska, D., Riemekasten, G., Vonk, M. C., Kowalczuk, O., Bielecki, M., Milewski, R., Chyczewski, L., Niklinski, J., & Kowal, K. (2012). The Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) Polymorphism Is Associated with Risk of Scleroderma-Related Interstitial Lung Disease: A Multicenter Study From the EULAR Scleroderma Trial and Research Group. Arthritis and Rheumatism, 64(10), S971-S971.

Kowal-Bielecka, Otylia M. ; Chwiesko-Minarowska, Sylwia ; Bernatowicz, Pawel et al. / The Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) Polymorphism Is Associated with Risk of Scleroderma-Related Interstitial Lung Disease : A Multicenter Study From the EULAR Scleroderma Trial and Research Group. In: Arthritis and Rheumatism. 2012 ; Vol. 64, No. 10. pp. S971-S971.

@article{4eaf0daf60dd460097f2a3fb800a64e7,

title = "The Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) Polymorphism Is Associated with Risk of Scleroderma-Related Interstitial Lung Disease: A Multicenter Study From the EULAR Scleroderma Trial and Research Group.",

author = "Kowal-Bielecka, {Otylia M.} and Sylwia Chwiesko-Minarowska and Pawel Bernatowicz and Yannick Allanore and Radstake, {Timothy R. D.} and Jasper Broen and Marco Matucci-Cerinic and Roger Hesselstrand and Dorota Krasowska and Gabriela Riemekasten and Vonk, {Madelon C.} and Oksana Kowalczuk and Marek Bielecki and Robert Milewski and Lech Chyczewski and Jacek Niklinski and Krzysztof Kowal",

year = "2012",

month = oct,

language = "English",

volume = "64",

pages = "S971--S971",

journal = "Arthritis and Rheumatism",

issn = "0004-3591",

publisher = "John Wiley & Sons Inc.",

number = "10",

note = "Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP) ; Conference date: 09-11-2012 Through 14-11-2012",

}

Kowal-Bielecka, OM, Chwiesko-Minarowska, S, Bernatowicz, P, Allanore, Y, Radstake, TRD, Broen, J, Matucci-Cerinic, M, Hesselstrand, R, Krasowska, D, Riemekasten, G, Vonk, MC, Kowalczuk, O, Bielecki, M, Milewski, R, Chyczewski, L, Niklinski, J & Kowal, K 2012, 'The Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) Polymorphism Is Associated with Risk of Scleroderma-Related Interstitial Lung Disease: A Multicenter Study From the EULAR Scleroderma Trial and Research Group.', Arthritis and Rheumatism, vol. 64, no. 10, pp. S971-S971.

The Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) Polymorphism Is Associated with Risk of Scleroderma-Related Interstitial Lung Disease: A Multicenter Study From the EULAR Scleroderma Trial and Research Group. / Kowal-Bielecka, Otylia M.; Chwiesko-Minarowska, Sylwia; Bernatowicz, Pawel et al.
In: Arthritis and Rheumatism, Vol. 64, No. 10, 10.2012, p. S971-S971.

Research output: Contribution to journal › Meeting Abstract › Other research output

TY - JOUR

T1 - The Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) Polymorphism Is Associated with Risk of Scleroderma-Related Interstitial Lung Disease

T2 - Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP)

AU - Kowal-Bielecka, Otylia M.

AU - Chwiesko-Minarowska, Sylwia

AU - Bernatowicz, Pawel

AU - Allanore, Yannick

AU - Radstake, Timothy R. D.

AU - Broen, Jasper

AU - Matucci-Cerinic, Marco

AU - Hesselstrand, Roger

AU - Krasowska, Dorota

AU - Riemekasten, Gabriela

AU - Vonk, Madelon C.

AU - Kowalczuk, Oksana

AU - Bielecki, Marek

AU - Milewski, Robert

AU - Chyczewski, Lech

AU - Niklinski, Jacek

AU - Kowal, Krzysztof

PY - 2012/10

Y1 - 2012/10

M3 - Meeting Abstract

SN - 0004-3591

VL - 64

SP - S971-S971

JO - Arthritis and Rheumatism

JF - Arthritis and Rheumatism

IS - 10

Y2 - 9 November 2012 through 14 November 2012

ER -

Kowal-Bielecka OM, Chwiesko-Minarowska S, Bernatowicz P, Allanore Y, Radstake TRD, Broen J et al. The Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) Polymorphism Is Associated with Risk of Scleroderma-Related Interstitial Lung Disease: A Multicenter Study From the EULAR Scleroderma Trial and Research Group. Arthritis and Rheumatism. 2012 Oct;64(10):S971-S971.